Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Verdura

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|February 19, 2021
Metformin: Targeting the Metabolo-Epigenetic Link in Cancer BiologyElisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo, et al.
Oncoimmunology|October 25, 2019
Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapySara Verdura, Elisabet Cuyàs, Begoña Martin-Castillo, et al.
Aging|December 9, 2022
Circulating levels of MOTS-c in patients with breast cancer treated with metforminElisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo, et al.
Nutrients|September 9, 2022
Nutritional Niches of Cancer Therapy-Induced Senescent CellsÀngela Llop-Hernández, Sara Verdura, Elisabet Cuyàs, et al.
Cancers|December 23, 2022
Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast CellsElisabet Cuyàs, Salvador Fernández-Arroyo, Sara Verdura, et al.
General and Comparative Endocrinology|December 3, 2014
Development of a flatfish-specific enzyme-linked immunosorbent assay for Fsh using a recombinant chimeric gonadotropinFrançois Chauvigné, Sara Verdura, María José Mazón, et al.
Cell Death Discovery|February 19, 2026
Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescenceÀngela Llop-Hernández, Sara Verdura, Júlia López, et al.
Biology of Reproduction|June 1, 2012
Follicle-stimulating hormone and luteinizing hormone mediate the androgenic pathway in Leydig cells of an evolutionary advanced teleostFrançois Chauvigné, Sara Verdura, María J Mazón, et al.
Expert Opinion on Therapeutic Targets|July 11, 2025
Metabolic hallmarks of trastuzumab resistanceBegoña Martin-Castillo, Sara Verdura, Àngela Llop-Hernández, et al.
American Journal of Cancer Research|June 13, 2022
Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signalingLin Yang, Travis Vander Steen, Ingrid Espinoza, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|February 19, 2021
Metformin: Targeting the Metabolo-Epigenetic Link in Cancer BiologyElisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo, et al.
Oncoimmunology|October 25, 2019
Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapySara Verdura, Elisabet Cuyàs, Begoña Martin-Castillo, et al.
Aging|December 9, 2022
Circulating levels of MOTS-c in patients with breast cancer treated with metforminElisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo, et al.
Nutrients|September 9, 2022
Nutritional Niches of Cancer Therapy-Induced Senescent CellsÀngela Llop-Hernández, Sara Verdura, Elisabet Cuyàs, et al.
Cancers|December 23, 2022
Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast CellsElisabet Cuyàs, Salvador Fernández-Arroyo, Sara Verdura, et al.
General and Comparative Endocrinology|December 3, 2014
Development of a flatfish-specific enzyme-linked immunosorbent assay for Fsh using a recombinant chimeric gonadotropinFrançois Chauvigné, Sara Verdura, María José Mazón, et al.
Cell Death Discovery|February 19, 2026
Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescenceÀngela Llop-Hernández, Sara Verdura, Júlia López, et al.
Biology of Reproduction|June 1, 2012
Follicle-stimulating hormone and luteinizing hormone mediate the androgenic pathway in Leydig cells of an evolutionary advanced teleostFrançois Chauvigné, Sara Verdura, María J Mazón, et al.
Expert Opinion on Therapeutic Targets|July 11, 2025
Metabolic hallmarks of trastuzumab resistanceBegoña Martin-Castillo, Sara Verdura, Àngela Llop-Hernández, et al.
American Journal of Cancer Research|June 13, 2022
Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signalingLin Yang, Travis Vander Steen, Ingrid Espinoza, et al.
Pageof 6